Analytical Specialist - CMC
Denne stilling er desværre ikke længere ledig.
Se alle ledige stillinger
Hørsholm
is looking for an experienced Analytical Specialist, to fill a newly established position in our small but growing CMC department.
As our new colleague and first Analytical CMC expert, you will primarily focus on collaborating with CDMOs, supporting early phase clinical trials with the development of analytical methods, validation activities, establishing specifications, supporting stability studies of both drug substance (synthetic peptides) and drug product, and ensuring the delivery of accompanying documentation.
We have a bold ambition to further expand our clinical pipeline within multiple disease areas. As part of the team, you will be able to influence and shape your job content in collaboration with your colleagues. You will work closely with the rest of the CMC team and the other departments in the area led by our Chief Medical and Development Officer, but also with the other departments in our Biotech business unit, in a friendly and helpful atmosphere, where we obtain ambitious results together.
Your main responsibilities
Professional qualifications
As a person you are flexible, can navigate and collaborate in an energetic and dynamic organization. You are proactive, self-motivated and keen on setting and delivering to deadlines.
You can build trust across professional and geographical boundaries; you are an excellent communicator and a team player that sees the value in reaching ambitious goals via a joint effort with the opportunity to grow along the way.
Application details
Please apply as soon as possible and no later than March 8, 2026 by uploading your motivated cover letter, CV and relevant diplomas on our website. If you have questions about the position, please contact Senior CMC Project Manager Francesca Macchi,
About Gubra
is a disease-agnostic techbio company specialized in peptide-based drug discovery and preclinical contract research services striving for excellence at all levels. We insist on doing things efficiently – and often differently - to reach the results we aim for. Our vision is to become leaders in the path towards a more sustainable and healthier world. We do that by facilitating the discovery of new medicine, and by acting and inspiring others to fight the ongoing climate and biodiversity crises.
Gubra’s activities are focused on the early stages of drug development and are organised in two main highly synergistic business areas: Biotech and CRO Services. We generate our revenue by performing research for life science companies as well as by partnering projects from our discovery and development pipeline.
Our therapeutic focus is within metabolic and fibrotic diseases, and we specialize in in vivo pharmacology, ex vivo assays, drug profiling, histology, stereology and whole brain and organ imaging. In addition, we offer a full palette of advanced transcriptomics. Our ML/AI-driven peptide drug discovery platform streaMLine enables us to rapidly develop a peptide hit into a non-clinical candidate ready for development. Through a constant focus on high quality, scientific excellence, speed, and solid teamwork we have established ourselves as a highly professional and competent partner in the market.
People are our greatest asset, and our team consists of around 300 employees. The mix of people from different cultures and educational backgrounds combined with our entrepreneurial mindset have greatly impacted our working environment, which is characterized by entrepreneurial drive, scientific curiosity, and teamwork – we join forces!
As our new colleague and first Analytical CMC expert, you will primarily focus on collaborating with CDMOs, supporting early phase clinical trials with the development of analytical methods, validation activities, establishing specifications, supporting stability studies of both drug substance (synthetic peptides) and drug product, and ensuring the delivery of accompanying documentation.
We have a bold ambition to further expand our clinical pipeline within multiple disease areas. As part of the team, you will be able to influence and shape your job content in collaboration with your colleagues. You will work closely with the rest of the CMC team and the other departments in the area led by our Chief Medical and Development Officer, but also with the other departments in our Biotech business unit, in a friendly and helpful atmosphere, where we obtain ambitious results together.
Your main responsibilities
- Overall responsibility for analytical methods development, with focus on RP-HPLC analyses of synthetic peptides, tech transfer and validation at CDMOs
- Collaborate with CDMOs (DS, DP, and other testing sites) on all analytical topics, including specifications and stability studies
- Drive operational deliverables in alignment with project goals
- Ensure compliant documentation for regulatory submissions
- Collaborate with internal stakeholders in the Biotech unit to continuously strengthen and optimize the analytical capabilities within our in-house laboratories
Professional qualifications
- PhD degree in chemistry, biochemistry, pharmacy or similar, with a minimum of 5 years of relevant experience from biotech or pharma
- Extensive experience with the analysis of peptides in early clinical development at CDMOs
- Strong collaboration, communication and stakeholder management skills
- Thorough understanding of GMP, regulatory requirements and relevant guidelines
- Experience in due diligence processes and collaboration with external partners is beneficial
As a person you are flexible, can navigate and collaborate in an energetic and dynamic organization. You are proactive, self-motivated and keen on setting and delivering to deadlines.
You can build trust across professional and geographical boundaries; you are an excellent communicator and a team player that sees the value in reaching ambitious goals via a joint effort with the opportunity to grow along the way.
Application details
Please apply as soon as possible and no later than March 8, 2026 by uploading your motivated cover letter, CV and relevant diplomas on our website. If you have questions about the position, please contact Senior CMC Project Manager Francesca Macchi,
About Gubra
is a disease-agnostic techbio company specialized in peptide-based drug discovery and preclinical contract research services striving for excellence at all levels. We insist on doing things efficiently – and often differently - to reach the results we aim for. Our vision is to become leaders in the path towards a more sustainable and healthier world. We do that by facilitating the discovery of new medicine, and by acting and inspiring others to fight the ongoing climate and biodiversity crises.
Gubra’s activities are focused on the early stages of drug development and are organised in two main highly synergistic business areas: Biotech and CRO Services. We generate our revenue by performing research for life science companies as well as by partnering projects from our discovery and development pipeline.
Our therapeutic focus is within metabolic and fibrotic diseases, and we specialize in in vivo pharmacology, ex vivo assays, drug profiling, histology, stereology and whole brain and organ imaging. In addition, we offer a full palette of advanced transcriptomics. Our ML/AI-driven peptide drug discovery platform streaMLine enables us to rapidly develop a peptide hit into a non-clinical candidate ready for development. Through a constant focus on high quality, scientific excellence, speed, and solid teamwork we have established ourselves as a highly professional and competent partner in the market.
People are our greatest asset, and our team consists of around 300 employees. The mix of people from different cultures and educational backgrounds combined with our entrepreneurial mindset have greatly impacted our working environment, which is characterized by entrepreneurial drive, scientific curiosity, and teamwork – we join forces!
Information og data
Denne ledige stilling har jobtypen "Øvrige", og befinder sig i kategorien "Øvrige stillinger".
Arbejdsstedet er beliggende i Hørsholm.
Jobbet er oprettet på vores service den 16.2.2026, men kan have været deaktiveret og genaktiveret igen.
- Øvrige
- Hørsholm
- Søndag den 08. marts 2026
Lignende jobs
-
Weekend og sommerferieafløsere til Sophienborg Ple...
Hos os handler arbejdet ikke kun om opgaver – men om mennesker. Du bliver en vigtig del af hverdagen for vores beboere, og vi sætter stor pris på alt det, du kommer med.Dig, som:Det vigtigste er, a..Få mere info- Øvrige
- Nordsjælland
-
Adv. IT System Management Professional (12-month p...
Are you enthusiastic about the opportunity to make a meaningful impact in managing IT Systems and Computerized Equipment? Do you want to be part of an innovative organization that values collaborat..Få mere info- Øvrige
- Hillerød
-
Finance Partner
Are you interested in finance partnering and controlling? Do you enjoy driving financial management across cross‑functional teams? And are you looking for a role where you can contribute to a posit..Få mere info- Øvrige
- Gentofte
-
Intern for Drug Product Manufactoring
Are you eager to gain hands-on experience within Drug Product manufacturing and contribute to a company with a strong purpose? We are looking for two Trainees to support our Aseptic Production and .Få mere info- Øvrige
- Nordsjælland
Statistik over udbudte jobs som øvrige i Hørsholm
Herunder ser du udviklingen i udbudte øvrige i Hørsholm over tid. Bemærk at jobs der ikke har en bestemt geografi ikke er medtaget i tabellen. I den første kolonne ser du datoen. I den næste kolonne ser du det samlede antal øvrige.
| Dato | Alle jobs som øvrige |
|---|---|
| 4. april 2026 | 15 |
| 3. april 2026 | 15 |
| 2. april 2026 | 15 |
| 1. april 2026 | 14 |
| 31. marts 2026 | 14 |
| 30. marts 2026 | 14 |
| 29. marts 2026 | 13 |
| 28. marts 2026 | 13 |
| 27. marts 2026 | 13 |
| 26. marts 2026 | 14 |
| 25. marts 2026 | 15 |
| 24. marts 2026 | 15 |
| 23. marts 2026 | 16 |
| 22. marts 2026 | 16 |
| 21. marts 2026 | 16 |
| 20. marts 2026 | 15 |
| 19. marts 2026 | 16 |
| 18. marts 2026 | 16 |
| 17. marts 2026 | 14 |
| 16. marts 2026 | 13 |
| 15. marts 2026 | 11 |
| 14. marts 2026 | 11 |
| 13. marts 2026 | 11 |
| 12. marts 2026 | 12 |
| 11. marts 2026 | 12 |
| 10. marts 2026 | 12 |
| 9. marts 2026 | 11 |
| 8. marts 2026 | 13 |
| 7. marts 2026 | 13 |
| 6. marts 2026 | 13 |
| 5. marts 2026 | 12 |